Strides arm and its partner get USFDA nod for hypokalemia treatment drug
The approved product, used in treatment of patients with hypokalemia, is a generic version of Merck, Inc's Potassium Chloride extended-release tablets, a regulatory filing said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Chloride | Klor-Con | Merck | Pharmaceuticals | Potassium | Potassium Chloride